Avicanna's 5th Medical Symposium on Cannabinoid Medicine
On June 6, a well-anticipated medical symposium will be hosted by Avicanna Inc., a prominent biopharmaceutical company dedicated to the innovative exploration of cannabinoid-based medicine. This exciting event, taking place at the MaRS Discovery District, aims to bring together healthcare practitioners and researchers to share knowledge and expand the understanding of cannabinoid treatments.
Event Highlights
The symposium, aptly titled "From Emerging Evidence to Clinical Practice," will delve into various topics surrounding cannabinoid medicine. Attendees can expect to hear from key opinion leaders and experts from both Canadian and international backgrounds. Highlighted speakers include renowned clinicians and scientists, who will present on the latest research and clinical practices.
Featured Speakers and Their Contributions
The quality of discussion at the symposium will be enhanced by presentations from a diverse group of experts:
- Dr. Carrie Cuttler from Washington State University will explore the therapeutic potential of cannabigerol without inducing a high.
- Dr. Jason McDougall from Dalhousie University will discuss the role of cannabinoids in managing arthritis.
- Carlo De Angelis from Sunnybrook Health Sciences Centre will present unique patient cases showcasing innovative uses of medical cannabis.
- Dr. Daniel Bear from Humber College will address considerations for medical cannabis education among healthcare professionals.
- Dr. Zachary Walsh from the University of British Columbia will cover new findings on cannabis use among high-risk populations.
- Dr. Kelly Dunn from Johns Hopkins School of Medicine will highlight evidence of interactions between opioids and cannabinoids.
- Dr. Hance Clarke from University Health Network will showcase the Canadian Medical Cannabis Clinical Trials Network.
- Dr. Jennifer Baumbusch from the University of British Columbia will present current research regarding cannabis use among older adults.
- Dr. Evan Lewis from North Toronto Neurology will discuss advancements in cannabis-based therapies for epilepsy.
The Importance of Knowledge Exchange
According to Dr. Karolina Urban, Executive Vice President of Medical Affairs at Avicanna, this symposium builds on the previous year's success. It aims to enhance collective understanding and facilitate meaningful dialogue on cannabinoid-based medicines across the medical community. This platform signifies a pivotal opportunity for collaboration and education.
Abstract Submissions for Poster Presentations
The symposium also encourages researchers and practitioners to submit abstracts for a dedicated poster presentation session. This initiative emphasizes ongoing knowledge exchange and may serve as an avenue for advancing research in cannabinoid-based medicine.
How to Register
Healthcare practitioners and researchers interested in attending the symposium can register and submit abstracts for poster presentations through Avicanna's website.
About Avicanna
Avicanna Inc. (TSX: AVCN, OTCQX: AVCNF, Frankfurt: 0NN) is devoted to promoting the advancement and commercialization of plant-derived cannabinoid products. The company has successfully developed a range of proprietary products, backed by extensive research and clinical development.
- RHO Phyto™ Medical Cannabis Formulary: Avicanna offers a wide spectrum of cannabinoid products including oral, sublingual, topical, and transdermal formulations, with a dedication to patient education.
- MyMedi.ca: This platform enhances the medical cannabis journey for patients, offering bilingual support programs and educational resources.
- Pharmaceutical Pipeline: Avicanna is advancing various clinical-stage cannabinoid candidates targeting dermatology, chronic pain, and neurological disorders.
- Aureus Santa Marta™: The active pharmaceutical ingredients supplied by Santa Marta Golden Hemp SAS support the development of high-quality cannabinoid products for international partners.
Frequently Asked Questions
What is the main focus of Avicanna's fifth medical symposium?
The symposium is focused on cannabinoid-based medicine and aims to bring together healthcare practitioners and researchers to share the latest findings and clinical practices.
Who are some of the featured speakers at the event?
Featured speakers include Dr. Carrie Cuttler, Dr. Jason McDougall, Carlo De Angelis, and many other distinguished experts in the field of cannabinoid medicine.
How can one register for the symposium?
Interested individuals can register and submit abstracts for poster presentations through the Avicanna website.
What type of topics will be discussed at the symposium?
Topics will cover a wide range of issues related to the therapeutic benefits, clinical applications, and research emerging in the field of cannabinoid medicine.
What is Avicanna's mission?
Avicanna's mission is to advance cannabinoid-based products and formulations to enhance the quality of care in the global medical and pharmaceutical markets.
